27 Jul 2022 , 04:07 PM
Results Date: 28th July
Recommendation: Buy
Target price: Rs4,800
Source: IIFL Research
June 2022 quarter revenue of Dr Reddy’s is forecasted at Rs54,128 million. This will be a y-o-y growth of 10.8%. PAT is forecasted at Rs6,790 million. This will be a y-o-y growth of 19.8%. Demand for drugs in areas such as Dermatology and Nephrology are expected to be higher in the June quarter.
Key management insights to look into:
June 2022 estimates | Y-o-Y | |
Revenue (Rs mn) | 54,128 | 10.8% |
PAT | 6,790 | 19.8% |
Source: Brokerage Reports
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.